GSK-204860

Study Sponsor: GSK

Study Title

A double-blind (sponsor unblinded) study to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effect of repeat dosing of GSK2646264 in cutaneous lupus erythematosus patients

Medicine or Vaccine (generic name)

GSK2646264

Sponsor Identification Number

204860

Trial Registry Identification Number(#'s)

NCT02927457 2016-000277-20

Medical Condition

Lupus Erythematosus, Cutaneous

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204860

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02927457

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-000277-20

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

February 2021